Screener
ASP Isotopes, Inc. ASPI Operating Income
Discontinued — last reported Q1 '26
Operating Income at other companies
Other financials
Where this comes from
Reported directly by ASP Isotopes, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: ASP Isotopes, Inc.’s 10-Q, filed May 20, 2026.
- Filed
- May 20, 2026, 4:26 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-232658
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Research and development | 5,263 | 1,530 |
| Selling, general and administrative | 21,291 | 6,749 |
| Total operating expenses | 26,554 | 8,279 |
| Loss from operations | (24,888) | (7,952) |
| Other (expense) income: | ||
| Foreign exchange transaction loss | (3,725) | (61) |
| Change in fair value of share liability | — | 12 |
| Change in fair value of convertible notes payable | (568) | (957) |
Item 1. Financial Statements.
FAQ
- What is ASP Isotopes, Inc.'s operating income?
- ASP Isotopes, Inc. (ASPI) reported operating income of -$24.89M in Q1 2026.
- How has ASP Isotopes, Inc.'s operating income changed year-over-year?
- ASP Isotopes, Inc.'s operating income decreased by 213.0% year-over-year, from -$7.95M to -$24.89M.
- What is the long-term trend for ASP Isotopes, Inc.'s operating income?
- Over 3 years (2022 to 2025), ASP Isotopes, Inc.'s operating income has grown at a 127.3% compound annual growth rate (CAGR), from -$5.1M to -$59.91M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about ASP Isotopes, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude